glucose and fluoxetine induce fine structural change in human serum albumin
Authors
abstract
human serum albumin has been used as a model protein for protein folding and ligand binding studies over many decades. due to its long life period and high concentration in plasma, hsa is highly sensitive to glycation. it is reported that 175 mg/dl glucose concentration is a threshold of kidney activity for the beginning of excretion of glucose. ph denaturation of hsa in absence and presence of different concentrations of glucose is studied and based on the pace two-state model, the findings are analyzed. in addition, florescence emission data of albumin range in the period of 300-500 nm was depicted. the amounts of free energy change and [d]1/2 parameters of unfolding in correspond to florescence date indicate that glucose induces fine structural change in human serum albumin. results showed that 175 mg/dl glucose concentration is a critical point for albumin structural and functional alteration.
similar resources
Glucose and Fluoxetine Induce Fine Structural Change in Human Serum Albumin
Human serum albumin has been used as a model protein for protein folding and ligand binding studies over many decades. Due to its long life period and high concentration in plasma, HSA is highly sensitive to glycation. It is reported that 175 mg/dL glucose concentration is a threshold of kidney activity for the beginning of excretion of glucose. pH denaturation of HSA in absence and presence of...
full textGlucose and Fluoxetine Induce Fine Structural Change in Human Serum Albumin
Human serum albumin has been used as a model protein for protein folding and ligand binding studies over many decades. Due to its long life period and high concentration in plasma, HSA is highly sensitive to glycation. It is reported that 175 mg/dL glucose concentration is a threshold of kidney activity for the beginning of excretion of glucose. pH denaturation of HSA in absence and presence of...
full textGlucose and Fluoxetine Induce Fine Structural Change in Human Serum Albumin
Human serum albumin has been used as a model protein for protein folding and ligand binding studies over many decades. Due to its long life period and high concentration in plasma, HSA is highly sensitive to glycation. It is reported that 175 mg/dL glucose concentration is a threshold of kidney activity for the beginning of excretion of glucose. pH denaturation of HSA in absence and presence of...
full textFluoxetine Competes with Cortisol for Binding to Human Serum Albumin
Human serum albumin (HSA) is an important protein that carries variety of substances like some hormones and drugs in blood. Pharmacological studies of the interaction of many drugs and HSA are reported during several decades, specially recently years. Interaction of cortisol and fluoxetine hydrochloride (FLX) (as a common anti-stress drug) with HSA (as their carrier in blood) has been studied s...
full textCo-amoxiclav Effects on the Structural and Binding Properties of Human Serum Albumin
Human serum albumin (HSA) is the most abundant plasma protein in the human body. HSA plays an important role in drug transport and metabolism. This protein has a high affinity to a very wide range of materials, including metals such as Cu2+ and Zn2+, fatty acids, amino acids and metabolites such as bilirubin and many drug compounds. In this study, we investigated the effects of co-amoxiclav, as...
full textSERUM GLUCOSE, BILIRUBIN, CALCIUM, PHOSPHORUS, PROTEIN AND ALBUMIN CONCENTRATIONS
Serum levels of glucose, bilirubin, calcium, phosphorus, protein and albumin were measured in a group of nine healthy men before, and on the first, 10th, 20th and 29th day of Rarnadan, and four weeks after Islamic fasting was terminated. There was a significant reduction in body weight, a significant increase in serum bilirubin and a slight decrease in calcium during Ramadan. Serum glucose decr...
full textMy Resources
Save resource for easier access later
Journal title:
the iranian journal of pharmaceutical researchجلد ۱۲، شماره ۱، صفحات ۱۸۵-۱۹۱
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023